Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Short Interest Down 18.6% in February
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) saw a large drop in short interest in February. As of February 28th, there was short interest totalling 93,000 shares, a drop of 18.6% from the February 13th total of 114,300 shares. Based on an average trading volume of 36,300 shares, the short-interest ratio is presently 2.6 days. […]